Curable is a U.S.-based tech startup established in 2016 with a focus on revolutionizing chronic pain therapy within the Health Care industry. Leveraging cutting-edge research on neuroplasticity, Curable provides an innovative software app that offers safe and effective therapy programs designed to alleviate conditions such as back pain, migraines, and fibromyalgia.
Recognizing the brain's role in the persistence and mitigation of physical pain, their approach can be described as "physical therapy for your brain," targeting a widespread challenge affecting an estimated 100 million American adults. This strategic emphasis on brain adaptability positions Curable uniquely within the digital therapeutics landscape.
The company last secured funding through an Angel Round on April 10, 2017. With its innovative solution and growing market demand, Curable presents a compelling opportunity for investors aiming to make impactful contributions to health tech advancements.